Abstract
The use of anabolic agents in meat producing animals is forbidden in Europe since 1988. Nevertheless, the possibility of widespread abuse of hormonal substances still exists, mainly due to economical benefits. The use of “omics” approach is a promising strategy to highlight anabolic hormone abuse by indirectly detecting their physiological action. In this context, the aim of this work was to set up a liquid chromatography – high resolution mass spectrometry based metabolomics workflow for the screening of a combined trenbolone acetate/estradiol implant abuse in cattle urine. Therefore, an untargeted metabolomics approach combining the information provided by reverse-phase liquid chromatography and hydrophilic interaction chromatography both coupled to high resolution mass spectrometry was developed and applied to characterize and compare cattle urinary metabolic profiles from non-implanted and implanted animals. The combination of both separation modes improved the metabolite information richness. Discrimination between treated and untreated animals was observed by application of multivariate statistical analysis. Moreover, OPLS models permitted to highlight the candidate biomarkers appearing as the ions which contribute the most in the observed discrimination. From the results obtained, metabolomics approaches can be considered as a powerful strategy for the detection of fraudulent anabolic treatments in cattle since global urinary metabolic response provides helpful discrimination.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.